Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Year Ended September 30, 2018; Provides Earnings Guidance for the Half Year and Year Ending September 30, 2019
November 19, 2018 at 02:04 pm
Share
Noevir Holdings Co., Ltd. announced consolidated earnings results for the year ended September 30, 2018. For the year, the company reported net sales of JPY 57,828 million against JPY 54,473 million a year ago. Operating income was JPY 11,343 million against JPY 9,986 million a year ago. Net income attributable to owners of the parent was JPY 7,842 million against JPY 7,077 million a year ago. EPS was JPY 228.56 against JPY 199.64 a year ago. Ordinary income was JPY 11,577 million against JPY 10,291 million a year ago.
For the half year, the company expects net sales of JPY 29,700 million, operating income of JPY 5,900 million, ordinary income of JPY 6,000 million, net income attributable to owners of the parent of JPY 2,500 million or JPY 73.19 per share.
For the year ending September 30, 2019, the company expects net sales of JPY 59,500 million, operating income of JPY 11,700 million, ordinary income of JPY 11,900 million, net income attributable to owners of the parent of JPY 8,000 million or JPY 234.22 per share.
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Year Ended September 30, 2018; Provides Earnings Guidance for the Half Year and Year Ending September 30, 2019